Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, indicating a new minor revision of the page; this reflects an update to the page’s documentation rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-09T09:13:53.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page version and related metadata.
    Difference
    0.1%
    Check dated 2026-07-25T18:20:14.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This signals a new build of the page rendering, without altering the study details.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:18.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a software version bump in the site metadata. This change does not modify study details, eligibility criteria, or any user-facing content.
    Difference
    0.1%
    Check dated 2026-06-27T06:26:58.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page adds a recruitment update stating 'No longer looking for participants' and introduces new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. Additionally, the Intervention/Treatment header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.5%
    Check dated 2026-06-13T05:09:14.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The page now displays revision: v3.5.5 at the bottom, replacing v3.5.4. This indicates a recent update to the site's revision label and rendering.
    Difference
    0.1%
    Check dated 2026-06-05T23:55:57.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.